98%
921
2 minutes
20
Background: Brain-computer interface (BCI) has been shown to be beneficial in improving lower limb motility in stroke, but their effectiveness on balance and attention is unclear. In addition, current BCIs are mostly in single-task mode. The BCI system used in this study was based on a dual-task model of motor imagery (MI) and virtual reality (VR). Previous studies have demonstrated that dual-task seems to be beneficial for balance and attention. The purpose of this study was to validate the effects of MI-VR-based dual-task BCI on balance and attention in participants with stroke.
Methods: This pilot, single-blind, randomized controlled trial involved 38 stroke participants, randomized to the BCI (BCI pedaling training) or control group (conventional pedaling). Both groups trained 20 min daily, 5 days a week for 4 weeks, alongside conventional rehabilitation. Thirty participants completed the program (mean age: 56.56 years, mean disease duration: 4.48 months). Assessments were made before and after 4 weeks. The primary outcome was the Berg Balance Scale (BBS), and secondary outcomes included the Timed Up and Go Test (TUGT), Fugl-Meyer Lower Extremity Assessment (FMA-LE), Symbol Digit Modalities Test (SDMT), and average attention index.
Results: 30 participants completed the study (14 in the BCI and 16 in the control group). The retention rates were 73.68% and 84.21% respectively. No adverse events were reported in this study and participants did not report any discomfort. The changes in BBS, TUGT and SDMT values in the BCI group were significantly better than those in the control group (P < 0.05). Average attention index of the BCI group's participants grew with the number of training sessions, and there was a significant difference comparing pre- to post-treatment (p < 0.05). The value of BBS change is linearly correlated with the value of SDMT change (F = 8.778, y = 0.59x + 1.90, P < 0.001).
Conclusions: This study initially showed positive effects of dual-task mode of BCI pedalling training on balance and attention in stroke participants. However, given the preliminary nature of this study and its limitations, the results need to be treated with caution. Trial registration Chinese Clinical Trial Registry Identifier: ChiCTR2300071522. Registered on 2023/05/17.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12395916 | PMC |
http://dx.doi.org/10.1186/s12984-025-01730-9 | DOI Listing |
J Psychiatr Res
September 2025
Genomics and Bioinformatics Group, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain; Genetics Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, 15706, Spain; Fund
Methylphenidate (MPH) is the first-line treatment for Attention-Deficit/Hyperactivity Disorder (ADHD), a condition that disrupts daily functioning. Research indicates that individuals with ADHD often experience sensory processing impairments, regardless of co-occurring conditions. Given the growing interest in pharmacogenetics to personalise treatments and minimise side effects, this study aims to characterise the sensory profiles of in child and youth ADHD patients treated with MPH and investigate potential pharmacogenetic biomarkers that could be associated with treatment outcomes or sensory-related side effects.
View Article and Find Full Text PDFDev Growth Differ
September 2025
Department of Biological Sciences, College of Arts, Sciences, and Education, Florida International University, Miami, Florida, USA.
Superoxide dismutases (SODs) are key regulators of reactive oxygen species (ROS) and redox balance. Although intracellular SODs have been extensively studied, growing attention has been directed toward understanding the roles of extracellular SODs in both Dictyostelium and mammalian systems. In Dictyostelium discoideum, SodC is a glycosylphosphatidylinositol (GPI)-anchored enzyme that modulates extracellular superoxide to regulate Ras, PI3K signaling, and cytoskeletal remodeling during directional cell migration.
View Article and Find Full Text PDFDisabil Rehabil Assist Technol
September 2025
Department of Special Needs Education and Rehabilitation, Department Pedagogy and Didactics for People with Physical and Motor Development Impairments and Chronic and Progressive Illnesses, Carl von Ossietzky University, Oldenburg, Germany.
Objectives: Many studies investigate the impact of assistive devices and technologies (AD/AT) on physical outcomes. The role of AD/ATs in everyday activities and participation of children with cerebral palsy (CP) has received much less attention. This review scopes the impact of AD/ATs by the activities and participation components of the International Classification of Functioning, Disability and Health (ICF) model.
View Article and Find Full Text PDFAdv Mater
September 2025
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Bone defect therapy frequently encounters bacterial infections and chronic inflammation, which impair bone regeneration and threaten implant stability. Iron oxide nanoparticles have attracted attention due to cost-effectiveness, biocompatibility, and metabolic safety. However, iron oxide nanoparticles still struggle to balance low-temperature efficient antibacterial activity, effective immunomodulation, and bone regeneration.
View Article and Find Full Text PDFACS Appl Mater Interfaces
September 2025
Organic Electronic Materials Laboratory, Department of Information Display, College of Sciences, Kyung Hee University, Seoul 02447, Republic of Korea.
Solution-processed phosphorescent inverted organic light-emitting diodes (s-IOLEDs) have garnered significant attention due to their excellent stability and high performance. However, frequently used inorganic electron transport layers usually cause exciton dissociation at the emitting layer interface, leading to low device efficiency and severe efficiency roll-off. In this work, we designed a cross-linkable triazine-grafted electron transport copolymer (PPDPT--PBCB) with a high triplet energy (3.
View Article and Find Full Text PDF